Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
18.60
+0.36 (1.97%)
May 29, 2026, 12:39 PM EDT - Market open
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $528.25 million as of May 29, 2026. Its market cap has decreased by -13.75% in one year.
Market Cap
528.25M
Enterprise Value
-76.39M
1-Year Change
-13.75%
Ranking
Category
Stock Price
$18.60
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $528.25M, an increase of 237.54%. That is a compound annual growth rate of 13.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 508.40M | -37.40% |
| Dec 31, 2025 | 812.10M | 43.76% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
| Sep 29, 2016 | 156.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeneDx Holdings | 1.49B |
| NeoGenomics | 1.33B |
| CareDx | 1.17B |
| Personalis | 1.15B |
| OPKO Health | 1.08B |
| Castle Biosciences | 670.60M |
| Myriad Genetics | 398.57M |
| Prenetics Global | 339.60M |